ROLLING MEADOWS, Ill., May 23, 2017 – Findings from the first ever American Society for Dermatologic Surgery Association (ASDSA) Patient-Centered/Directed Outcomes for Skin Cancer Roundtable were recently published by the American Society of Clinical Oncology(ASCO) prior to its annual meeting. The roundtable – funded by the Patient-Centered Outcomes Research Institute (PCORI) – focuses on skin cancer treatments and patient satisfaction.

“ASDSA is thrilled ASCO recognized the importance of including the patient perspective in skin cancer treatment,” said ASDSA President Thomas Rohrer, MD. “This data gives qualitative information on the specific concerns of skin cancer patients, which has contributed positively to patient and medical research literature and merited the need for further study.”

Along with external partners, the American Cancer Society, the Cancer Support Community and the Partnership to Improve Patient Care, ASDSA recognized the unmet need of hearing the patient’s voice on what they thought was most important regarding the outcomes of their skin cancer treatments.

Patients at the August 2016 summit wanted to be involved in the decision-making process and had high expectations for physician-patient communication. The group also rated patient education as an expectation during their skin cancer treatment. Additional findings showed that most patients were concerned about the ability to return to normal function, scarring from treatment and concern of subsequent tumors or recurrence of the primary tumor, as high priority areas for patients undergoing skin cancer treatment.

To further the research, ASDSA is currently applying for an additional contract to study non-melanoma skin cancer in patients over the age of 65 and patients who have been diagnosed with genetic skin cancer syndromes.

# # #

With a membership of over 6,100 physicians, the American Society for Dermatologic Surgery Association, a 501(c) (6) association, speaks in a unified voice to advocate, promote and advance dermatology surgery and its patients. For more information, visit or email